EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Age‐linked biological context shapes adaptive immunity in Alzheimer's disease

Sophie Shirenova iD, Arya Biragyn, Eitan Okun

Alzheimer's & Dementia · 2026-11 · 22 (11)

DOI: 10.1002/alz.71978 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.11.2026. Verfasst von Sophie Shirenova und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Alzheimer Disease, Adaptive Immunity, Aging. Die Arbeit nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Association, AARG-22-974362, National Institute on Aging, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is increasingly recognized as a neuroimmune disorder with protective or pathogenic adaptive immunity dependent on the biological context. This review synthesizes evidence from human studies, genetic analyses, mouse models, and clinical trials to examine how lymphocytes and humoral immunity influence AD. Human studies show T‐cell accumulation in disease‐relevant brain compartments, peripheral B‐cell remodeling, endogenous anti‐amyloid beta antibodies, and cytokine dysregulation. Complementary genetic studies implicate antigen presentation, lymphocyte regulation, immunoglobulin signaling, and immune checkpoints in AD susceptibility. The findings indicate that the consequences of adaptive immune engagement vary with age and disease stage and are further modified by sex, genetic context, and therapeutic modality. Adaptive immunity in AD is therefore dynamic rather than uniformly beneficial or detrimental. Age in particular emerges as a major determinant that biases immune responses from earlier regulatory states toward later maladaptive inflammation, providing a framework to reconcile conflicting findings and guide stage‐aware immunomodulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAdaptive ImmunityAgingHumansAnimalsBrainT-Lymphocytes

Stichwörter der Autor:innen

Alzheimer's diseaseB cellsT cellsadaptive immunityagingneuroinflammation

Autor:innen und Institutionen

  • The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.
  • The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, Israel.
  • The Paul Feder Laboratory for Alzheimer's Disease Research, Bar-Ilan University, Ramat Gan, Israel.
  • Laboratory of Molecular Biology and Immunology, National Institute on Aging, Immunoregulation Section, National Institutes of Health, Baltimore, Maryland, USA.

ORCID-Profile: Sophie Shirenova

Förderung

  • Alzheimer's Association
  • AARG-22-974362
  • National Institute on Aging, NIH

Zitieren

APA

Shirenova, S., Biragyn, A., & Okun, E. (2026). Age‐linked biological context shapes adaptive immunity in Alzheimer's disease. Alzheimer's & Dementia, 22(11). https://doi.org/10.1002/alz.71978

Vancouver

Shirenova S, Biragyn A, Okun E. Age‐linked biological context shapes adaptive immunity in Alzheimer's disease. Alzheimer's & Dementia. 2026;22(11). doi:10.1002/alz.71978

BibTeX
@article{Shirenova2026,
  author = {Shirenova, Sophie and Biragyn, Arya and Okun, Eitan},
  title = {Age‐linked biological context shapes adaptive immunity in Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {11},
  doi = {10.1002/alz.71978}
}
Kostenlos starten →